eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | retinopathy, diabetic |
| Comorbidity | C0011847|diabetes |
| Sentences | 91 |
| PubMedID- 25253986 | Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy. |
| PubMedID- 26089211 | Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in catalonia (spain). |
| PubMedID- 23737475 | Understanding the effect of adiponectin on the retinal vasculature may help improve potential therapies for retinal vascular disorders, especially diabetic retinopathy in patients with type 2 diabetes mellitus. |
| PubMedID- 21775752 | diabetes complications include diagnosis of diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, and diabetic peripheral vascular disease. |
| PubMedID- 24146865 | Objective: to evaluate the incidence of diabetic retinopathy in patients with type 2 diabetes mellitus, to identify the risk factors associated with the incidence of retinopathy and to develop a risk table to predict four-year retinopathy risk stratification for clinical use, from a four-year cohort study. |
| PubMedID- 23804745 | Results: twenty-two percent of survey respondents with diabetes had been diagnosed with diabetic retinopathy. |
| PubMedID- 26476835 | Background: to investigate the need for closer perioperative monitoring of diabetic retinopathy in patients with type 2 diabetes undergoing bariatric surgery. |
| PubMedID- 23955724 | Objectives: to evaluate the effect of mean platelet volume (mpv) on diabetic retinopathy in patients with type 2 diabetes mellitus. |
| PubMedID- 25352722 | Prolonged diabetes ultimately leads to diabetic retinopathy (dr) which is one of the leading causes of preventable blindness in the world. |
| PubMedID- 22137363 | diabetic retinopathy screening in patients with diabetes mellitus in primary care: incentives and barriers to screening attendance. |
| PubMedID- 25995613 | Among patients with diabetes, the presence of diabetic retinopathy was not associated with a higher prevalence of metabolic syndrome; metabolic syndrome was observed in 67.5% (135/200) of patients with retinopathy and 73% (73/100) of diabetics without retinopathy (p=0.36) (or =0.77; 95% ci: 0.45–1.32; p=0.34) (figure 1 and table 2). |
| PubMedID- 21418090 | Conclusions: our findings suggest that there is a dramatically increased prevalence of acquired colour vision impairment in type 2 diabetes patients without diabetic retinopathy which might be attributable to another pathogenesis associated with diabetic retinopathy. |
| PubMedID- 22541650 | Slr11, released from immature vascular cells and indicating the development of atherosclerosis, is expected to be a novel candidate biomarker indicating diabetic retinopathy in patients with type 2 diabetes mellitus. |
| PubMedID- 21851000 | [role of vascular endothelial growth factor and monocyte chemoattractant protein-1 in the development of endothelial dysfunction in types 1 and 2 diabetes mellitus complicated by diabetic retinopathy]. |
| PubMedID- 25226393 | Methods: blood samples were obtained from 62 type 1 and 80 type 2 diabetes patients with high-risk proliferative diabetic retinopathy and 81 healthy controls. |
| PubMedID- 24972631 | Insulin and risk of diabetic retinopathy in patients with type 2 diabetes mellitus: data from a meta-analysis of seven cohort studies. |
| PubMedID- 25143261 | The prognosis of diabetic retinopathy in patients with type 2 diabetes since 1996-1998: the skaraborg diabetes register. |
| PubMedID- 22362115 | Therefore, on the present evidence, annual screening is not necessary for people with type 2 diabetes with no lesions of diabetic retinopathy seen on digital images. |
| PubMedID- 24624806 | [results of antioxidant therapy for non-proliferative diabetic retinopathy in patients with type 2 diabetes mellitus]. |
| PubMedID- 20585003 | As such, our data are in good agreement with a previous study indicating increased retinal blood flow in diabetes before the onset of diabetic retinopathy (4). |
| PubMedID- 22876931 | The exclusion criteria were (1) previous ocular surgery, (2) diabetes mellitus with diabetic retinopathy, (3) previous macular laser photocoagulation, (4) previous intravitreal injection of anti-vegf agents or triamcinolone acetonide, (5) a history of ocular inflammation, (6) marked retinal hemorrhage (including macular bleeding involving the intrafoveal or subfoveal spaces), (7) coexisting ocular disease (i.e., epiretinal membrane or glaucoma), and (8) retreatment during the 6-month follow-up period. |
| PubMedID- 22427765 | Demonstrated the presence of diabetic retinopathy in patients with type 2 diabetes [15]. |
| PubMedID- 21886023 | Background: to examine prevalence and associated factors of diabetic retinopathy in patients with type 2 diabetes mellitus in urban communities of beijing. |
| PubMedID- 23885750 | Purpose: to investigate the relationship between retinal fractal dimensions (dfs) and retinal circulation, which is impaired in early-stage diabetic retinopathy (dr) in patients with type 2 diabetes mellitus (dm). |
| PubMedID- 22426176 | Purpose: to determine the correlation between axial length and diabetic retinopathy (dr) in patients with diabetes mellitus for 10 years or more. |
| PubMedID- 24707168 | Materials and methods: a total of 151 eyes from 80 patients from the retina department of istanbul training and research hospital who had type 2 diabetes mellitus with diabetic retinopathy were studied retrospectively in this cross-sectional research. |
| PubMedID- 24380004 | Predictors of diabetic retinopathy in patients with type 2 diabetes who have normoalbuminuria. |
| PubMedID- 23620476 | The overall prevalence of diabetic retinopathy among patients with type 2 diabetes has remained stable over the past 20 years despite an increase in the prevalence of diabetes (12). |
| PubMedID- 21586840 | Second, we confirmed that pct had significant correlation with cafs, diabetes duration, and stage of diabetic retinopathy, as mentioned in previous reports. |
| PubMedID- 26310005 | Aim: to investigate changes in clinical, functional, and morphological parameters of the retina in type 2 diabetes patients with diabetic retinopathy (dr) and those with combined fundus pathology (dr plus age-related macular degeneration (amd)) before and after a course of antioxidants and angioprotectors in the form of mono- or combination therapy. |
| PubMedID- 24864506 | [diabetic retinopathy in patients with type 1 diabetes mellitus]. |
| PubMedID- 24325604 | Exclusion criteria were (1) previous ocular surgery or intravitreous injection of anti-vegf agents or triamcinolone acetonide, (2) diabetes mellitus with diabetic retinopathy, (3) iris rubeosis, and (4) a history of ocular inflammation or vitreoretinal disease. |
| PubMedID- 21447662 | Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the netherlands. |
| PubMedID- 23033236 | Ethnic differences in the prevalence of diabetic retinopathy in persons with diabetes when first presenting at a diabetes clinic in south africa. |
| PubMedID- 21323731 | Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. |
| PubMedID- 22966098 | A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease. |
| PubMedID- 19681913 | Polymorphisms of the ucp2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus. |
| PubMedID- 22553643 | Aim: to determine the epidemiological characteristics and estimate the risk factors of diabetic retinopathy (dr) in patients with type 2 diabetes mellitus (t2dm) in shandong peninsula of china. |
| PubMedID- 22510012 | Objective: retinal endothelial dysfunction is a key in the etiogenesis of diabetic retinopathy (dr), in patients with type 2 diabetes mellitus (dm). |
| PubMedID- 24217637 | Body fat distribution and adipokine secretion are not associated with diabetic retinopathy in patients with type 2 diabetes mellitus. |
| PubMedID- 20151767 | Methods: fity-three type 2 diabetes patients with known diabetic retinopathy were studied. |
| PubMedID- 24363502 | Some studies have shown the correlation between obesity and diabetic retinopathy in patients with type 2 diabetes [34, 47, 48]. |
| PubMedID- 21600659 | Conclusions: elevated serum bilirubin levels may be protective against diabetic retinopathy among persons with either diabetes or impaired glucose metabolism, independent of known risk factors for diabetic retinopathy. |
| PubMedID- 21331741 | [5] reported that the cumulative incidence of diabetic retinopathy increased linearly with duration of diabetes, whereas the occurrence of nephropathy was almost none after 20–25 years of diabetes duration, and only a modest number of individuals with diabetes (~30%) developed diabetic nephropathy. |
| PubMedID- 21136234 | Purpose: the purpose of this study was the comparison of risk factors for development or progression of diabetic retinopathy in patients with type 2 diabetes between patients of a laser therapy center and a diabetes outpatient clinic. |
| PubMedID- 20698126 | Visual evoked potential can be used to detect a prediabetic form of diabetic retinopathy in patients with diabetes mellitus type i. |
| PubMedID- 21797106 | Aim: the aim of this study was to analyze the correlation between serum levels of inflammatory cytokines il-1beta, il-6, tnf-alpha and vegf and the presence and severity of diabetic retinopathy (dr) in patients with type 2 diabetes mellitus (dm). |
| PubMedID- 20515457 | Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. |
| PubMedID- 26313889 | diabetes triggers the development of ocular diseases like diabetic retinopathy and cataracts which are the leading cause of blindness around the world. |
| PubMedID- 24280592 | diabetic retinopathy was significantly associated with duration of diabetes whereas abnormal foot sensation was significantly associated with duration of diabetes and glycaemic control. |
Page: 1 2